SCHEMBL2010317

SCHEMBL2010317

CCSc1c(O)ccc(C(C)=O)c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
CYP2C9 P11712 3/20 0.39
CYP2C19 P33261 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 6/20 0.39
HPGD P15428 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
GAA P10253 3/20 0.39
MAPK1 P28482 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
ALOX15 P16050 2/20 0.39
PRKCI P41743 1/20 0.38
HSD17B1 P14061 2/20 0.37
KDM4E B2RXH2 3/20 0.36
CYP3A4 P08684 2/20 0.36
MEN1 O00255 2/20 0.36
POLB P06746 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2012899 0.74 GAA (0.36) ALDH1A1MAPTHPGDGAAMAPK1
SCHEMBL2013268 0.73 CASP3 (0.45) ALDH1A1CYP2C9CYP2C19MAPTHPGD
SCHEMBL9498871 0.72 ALDH1A1 (0.38) ALDH1A1CYP2C19CYP1A2CYP2D6MAPT
Gallacetophenone SCHEMBL105704 0.72 SELL (0.62) ALDH1A1CYP2C9CYP2C19CYP1A2CYP2D6
Gallacetophenone SCHEMBL29537961 0.72 SELL (0.62) ALDH1A1CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL2009246 0.72 ALDH1A1 (0.53) ALDH1A1CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL21951042 0.71 ALDH1A1 (0.47) ALDH1A1HPGDMAPK1HSD17B1CYP3A4
SCHEMBL30003813 0.71 ALDH1A1 (0.47) ALDH1A1HPGDMAPK1HSD17B1CYP3A4
SCHEMBL30736074 0.69 CYP1A2 (0.50) ALDH1A1CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL480388 0.69 CYP1A2 (0.50) ALDH1A1CYP2C9CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964628-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-06-21 US disclosed
US-20100256161-A1 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-10-07 US disclosed
US-7759387-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-07-20 US disclosed
US-20070021489-A1 Fibrinogen receptor antagonists and their use NICHOLAS PIRAMAL INDIA LIMITED (IN) 2007-01-25 US disclosed
EP-1677783-A2 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE Nicholas Piramal India Limited (IN) 2006-07-12 EP disclosed
WO-2005035495-A2 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE NICHOLAS PIRAMAL INDIA LIMITED (IN) 2005-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256161-A1 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE FGB, F13B, F2 ALDH1A1 2548/4885CYP2C9 412/4885CYP2C19 327/4885
US-20070021489-A1 Fibrinogen receptor antagonists and their use FGB, F13B, F2 ALDH1A1 2548/4885CYP2C9 412/4885CYP2C19 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.